China Revives Heavy Naval Firepower With New 155mm Gun That “Could Support An Attack On Taiwan”June 17, 2026
Analysis Y-mAbs: They Have Earnings, But Still Seek The Big HitOctober 14, 2023 anamejia18/iStock via Getty Images Topline Summary Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) is a commercial-stage biotech company producing antibody-based therapies for the…
